...
search icon
lfcr-img

Lifecore Biomedical Inc., Common Stock

LFCR

NSQ

$6.94

+$0.08

(1.17%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$254.36M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
13.60K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.67
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.68 L
$7.99 H
$6.94

About Lifecore Biomedical Inc., Common Stock

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameLFCRSectorS&P500
1-Week Return-0.15%1.99%1.17%
1-Month Return-1.72%-0.21%3.45%
3-Month Return11.18%-8.12%7.54%
6-Month Return-5.77%-5.84%0.01%
1-Year Return16.27%-7.68%12.59%
3-Year Return-29.79%8.12%54.74%
5-Year Return-37.64%32.14%89.07%
10-Year Return-53.17%81.24%186.76%

Financials

May '20May '21May '22May '23May '245YR TREND
Total Revenue590.37M544.16M185.79M185.79M128.26M[{"date":"2020-05-31","value":100,"profit":true},{"date":"2021-05-31","value":92.17,"profit":true},{"date":"2022-05-31","value":31.47,"profit":true},{"date":"2023-05-31","value":31.47,"profit":true},{"date":"2024-05-31","value":21.73,"profit":true}]
Cost of Revenue515.38M462.69M135.42M135.23M86.41M[{"date":"2020-05-31","value":100,"profit":true},{"date":"2021-05-31","value":89.78,"profit":true},{"date":"2022-05-31","value":26.28,"profit":true},{"date":"2023-05-31","value":26.24,"profit":true},{"date":"2024-05-31","value":16.77,"profit":true}]
Gross Profit74.99M81.47M50.37M50.55M41.85M[{"date":"2020-05-31","value":92.04,"profit":true},{"date":"2021-05-31","value":100,"profit":true},{"date":"2022-05-31","value":61.82,"profit":true},{"date":"2023-05-31","value":62.05,"profit":true},{"date":"2024-05-31","value":51.37,"profit":true}]
Gross Margin12.70%14.97%27.11%27.21%32.63%[{"date":"2020-05-31","value":38.93,"profit":true},{"date":"2021-05-31","value":45.89,"profit":true},{"date":"2022-05-31","value":83.09,"profit":true},{"date":"2023-05-31","value":83.39,"profit":true},{"date":"2024-05-31","value":100,"profit":true}]
Operating Expenses83.29M75.59M53.97M50.47M49.04M[{"date":"2020-05-31","value":100,"profit":true},{"date":"2021-05-31","value":90.75,"profit":true},{"date":"2022-05-31","value":64.8,"profit":true},{"date":"2023-05-31","value":60.6,"profit":true},{"date":"2024-05-31","value":58.88,"profit":true}]
Operating Income(8.30M)(6.86M)(3.60M)3.46M(8.84M)[{"date":"2020-05-31","value":-239.99,"profit":false},{"date":"2021-05-31","value":-198.47,"profit":false},{"date":"2022-05-31","value":-104.05,"profit":false},{"date":"2023-05-31","value":100,"profit":true},{"date":"2024-05-31","value":-255.75,"profit":false}]
Total Non-Operating Income/Expense(14.27M)(36.26M)(65.79M)(27.01M)268.00K[{"date":"2020-05-31","value":-5324.25,"profit":false},{"date":"2021-05-31","value":-13529.85,"profit":false},{"date":"2022-05-31","value":-24549.63,"profit":false},{"date":"2023-05-31","value":-10079.1,"profit":false},{"date":"2024-05-31","value":100,"profit":true}]
Pre-Tax Income(51.31M)(40.47M)(52.12M)(51.92M)9.51M[{"date":"2020-05-31","value":-539.28,"profit":false},{"date":"2021-05-31","value":-425.33,"profit":false},{"date":"2022-05-31","value":-547.77,"profit":false},{"date":"2023-05-31","value":-545.75,"profit":false},{"date":"2024-05-31","value":100,"profit":true}]
Income Taxes(13.12M)(7.80M)(5.84M)(5.84M)183.00K[{"date":"2020-05-31","value":-7167.21,"profit":false},{"date":"2021-05-31","value":-4262.84,"profit":false},{"date":"2022-05-31","value":-3190.71,"profit":false},{"date":"2023-05-31","value":-3190.71,"profit":false},{"date":"2024-05-31","value":100,"profit":true}]
Income After Taxes(38.19M)(32.66M)(46.28M)(46.08M)9.33M[{"date":"2020-05-31","value":-409.29,"profit":false},{"date":"2021-05-31","value":-350.07,"profit":false},{"date":"2022-05-31","value":-495.94,"profit":false},{"date":"2023-05-31","value":-493.88,"profit":false},{"date":"2024-05-31","value":100,"profit":true}]
Income From Continuous Operations(38.19M)(32.66M)(46.28M)(69.00M)9.33M[{"date":"2020-05-31","value":-409.29,"profit":false},{"date":"2021-05-31","value":-350.07,"profit":false},{"date":"2022-05-31","value":-495.94,"profit":false},{"date":"2023-05-31","value":-739.5,"profit":false},{"date":"2024-05-31","value":100,"profit":true}]
Income From Discontinued Operations(16.32M)(23.10M)(51.16M)(33.19M)-[{"date":"2020-05-31","value":-1632000000,"profit":false},{"date":"2021-05-31","value":-2309600000,"profit":false},{"date":"2022-05-31","value":-5115500000,"profit":false},{"date":"2023-05-31","value":-3318700000,"profit":false},{"date":"2024-05-31","value":"-","profit":true}]
Net Income(38.19M)(32.66M)(97.43M)(46.08M)12.01M[{"date":"2020-05-31","value":-317.91,"profit":false},{"date":"2021-05-31","value":-271.91,"profit":false},{"date":"2022-05-31","value":-811.05,"profit":false},{"date":"2023-05-31","value":-383.62,"profit":false},{"date":"2024-05-31","value":100,"profit":true}]
EPS (Diluted)(0.23)(0.11)(0.27)(1.66)(1.07)[{"date":"2020-05-31","value":-23,"profit":false},{"date":"2021-05-31","value":-11,"profit":false},{"date":"2022-05-31","value":-27,"profit":false},{"date":"2023-05-31","value":-166,"profit":false},{"date":"2024-05-31","value":-107.17,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

LFCR
Cash Ratio 0.17
Current Ratio 2.71
Quick Ratio 1.59

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LFCR
ROA (LTM) -3.11%
ROE (LTM) -83.58%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LFCR
Debt Ratio Lower is generally better. Negative is bad. 0.99
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.01

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LFCR
Trailing PE NM
Forward PE 8.67
P/S (TTM) 1.95
P/B 112.62
Price/FCF NM
EV/R 2.89
EV/Ebitda 8.11
PEG 3.51

FAQs

What is Lifecore Biomedical Inc. share price today?

Lifecore Biomedical Inc. (LFCR) share price today is $6.94

Can Indians buy Lifecore Biomedical Inc. shares?

Yes, Indians can buy shares of Lifecore Biomedical Inc. (LFCR) on Vested. To buy Lifecore Biomedical Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LFCR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Lifecore Biomedical Inc. be purchased?

Yes, you can purchase fractional shares of Lifecore Biomedical Inc. (LFCR) via the Vested app. You can start investing in Lifecore Biomedical Inc. (LFCR) with a minimum investment of $1.

How to invest in Lifecore Biomedical Inc. shares from India?

You can invest in shares of Lifecore Biomedical Inc. (LFCR) via Vested in three simple steps:

  • Click on Sign Up or Invest in LFCR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Lifecore Biomedical Inc. shares
What is Lifecore Biomedical Inc. 52-week high and low stock price?

The 52-week high price of Lifecore Biomedical Inc. (LFCR) is $7.99. The 52-week low price of Lifecore Biomedical Inc. (LFCR) is $3.68.

What is Lifecore Biomedical Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Lifecore Biomedical Inc. (LFCR) is 112.62

What is the Market Cap of Lifecore Biomedical Inc.?

The market capitalization of Lifecore Biomedical Inc. (LFCR) is $254.36M

What is Lifecore Biomedical Inc.’s stock symbol?

The stock symbol (or ticker) of Lifecore Biomedical Inc. is LFCR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top